Original Research

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode

Findling RL, Ginsberg LD

Neuropsychiatric Disease and Treatment 2014, 10:1589-1597

Published Date: 27 August 2014